For information concerning this clinical site, please contact Nymox at 800-936-9669.

Dallas, Texas 75231

0 studies enrolling now · 2 studies all time

What they study most

BPH, Benign Prostatic Hyperplasia, LUTS, Lower Urinary Tract Symptoms (LUTS)

Studies at this site

• Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022) — Completed
• Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) — Completed